National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1684, USA.
Emerg Infect Dis. 2010 Sep;16(9):1341-8. doi: 10.3201/eid1609.091800.
Chronic granulomatous disease (CGD) is characterized by frequent infections, most of which are curable. Granulibacter bethesdensis is an emerging pathogen in patients with CGD that causes fever and necrotizing lymphadenitis. However, unlike typical CGD organisms, this organism can cause relapse after clinical quiescence. To better define whether infections were newly acquired or recrudesced, we use comparative bacterial genomic hybridization to characterize 11 isolates obtained from 5 patients with CGD from North and Central America. Genomic typing showed that 3 patients had recurrent infection months to years after apparent clinical cure. Two patients were infected with the same strain as previously isolated, and 1 was infected with a genetically distinct strain. This organism is multidrug resistant, and therapy required surgery and combination antimicrobial drugs, including long-term ceftriaxone. G. bethesdensis causes necrotizing lymphadenitis in CGD, which may recur or relapse.
慢性肉芽肿病(CGD)的特征是频繁感染,其中大多数是可治愈的。Granulibacter bethesdensis 是 CGD 患者的一种新兴病原体,可引起发热和坏死性淋巴结炎。然而,与典型的 CGD 病原体不同,该病原体在临床静止后可导致复发。为了更好地确定感染是新获得的还是复发的,我们使用比较细菌基因组杂交技术来描述从北美和中美洲的 5 名 CGD 患者中获得的 11 个分离株。基因组分型表明,3 名患者在明显临床治愈数月至数年后出现反复感染。2 名患者感染了与之前分离的相同菌株,1 名患者感染了遗传上不同的菌株。该病原体具有多重耐药性,治疗需要手术和联合使用抗菌药物,包括长期使用头孢曲松。G. bethesdensis 在 CGD 中引起坏死性淋巴结炎,可能会复发或再发。